Company: RGNT
Filing Date: 2025-10-24
Form Type: F-1/A
Source: 0001213900-25-101900
Chunk: 307

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-10-24
Form: F-1/A
Chunk 307
---
 and
therefore unenforceable.

<div align='center'>II-2</div>

Item 7. Recent Sales of Unregistered Securities.

The following list sets
forth information as to all securities we have sold since October 2022, which were not registered under the Securities Act.

Between August 2020 and
February 2021, we entered into several convertible loan agreements for total consideration of $900,000, or the 2020 CLAs. In October
2024, we proposed to the lenders under the 2020 CLAs to increase the principal amount under their respective portion of the 2020 CLA,
up to an additional aggregate amount of $340,000, or the October 2024 Addendum, so that the 2020 CLAs shall bear interest at 8% per annum
until maturity commencing as of July 1, 2024 with respect to non-participating lenders and March 31, 2025 with respect to participating
lenders. In addition, pursuant to the October 2024 Addendum, upon the occurrence of an initial public offering based on a pre money valuation
of $5.15 million, the 2020 CLAs shall be automatically converted into 609,888 Ordinary Shares and the Additional Amount in addition to
the Risk Premium (each as defined therein) shall be automatically converted into 553,640 Ordinary Shares, which will occur upon the completion
of this offering. As of October 24, 2025, the Company received $450,000 in proceeds.

In September 2021, we
entered into several convertible loan agreements, or the 2021 CLAs, pursuant to which we obtained a convertible loan in the aggregate
amount of $835,000. In connection with the 2021 CLAs, the lenders were granted warrants to purchase shares of the Company of the same
class of the conversion securities. Effective as of March 11, 2024, the 2021 CLAs were converted into 88,385 Ordinary Shares and the
warrants granted thereunder expired in full in December 2023.

Between October 2024
and November 2024, we entered into Bridge Loans, pursuant to which we obtained a bridge loan from certain lenders, including certain
related parties. In October 2024, we amended the Bridge Loans pursuant to which the Bridge Loans have been extended until August 31,
2025 and during September 2025, the Bridge Loans were further extended to